Why Albireo Pharma Stock Is Skyrocketing Today
The company reported positive data from a clinical trial.
Albireo Pharma, Inc.
ALBO
ALBO
$36.68
-$0.10
-0.3%
Price as of February 24, 2021, 9:00 p.m. EST
View Interactive ALBO Charts
A specialty pharmaceutical company, which focused on the development and commercialization of innovative treatments for endocrine disorders such as diabetes and osteoporosis.
Interactive Chart
News & Analysis: Albireo Pharma, Inc.
Albireo Pharma, Inc. (ALBO) Q2 2020 Earnings Call Transcript
ALBO earnings call for the period ending June 30, 2020.
Albireo Pharma, Inc. (ALBO) Q1 2020 Earnings Call Transcript
ALBO earnings call for the period ending March 31, 2020.
Albireo Pharma, Inc. (ALBO) Q4 2019 Earnings Call Transcript
ALBO earnings call for the period ending December 31, 2019.
Albireo Pharma, Inc. (ALBO) Q3 2019 Earnings Call Transcript
ALBO earnings call for the period ending September 30, 2019.
Albireo Pharma, Inc. (ALBO) Q2 2019 Earnings Call Transcript
ALBO earnings call for the period ending June 30, 2019.
Albireo Pharma, Inc. (ALBO) Q1 2019 Earnings Call Transcript
ALBO earnings call for the period ending March 31, 2019.
Albireo Pharma, Inc. (ALBO) Q4 2018 Earnings Conference Call Transcript
ALBO earnings call for the period ending December 31, 2018.
Is This a MannKind Killer?
We'll know soon enough if Biodel's BIOD-123 has what it takes.
The Big Money Says to Sell MannKind
Should you be dumping this stock, too?
